XML 37 R24.htm IDEA: XBRL DOCUMENT
v3.25.1

Options | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Options | Note 13 – Options The 2020 Equity Plan was approved by written consent of a majority of shareholders of record as of November 12, 2019 and adopted by the Board of Directors on December 5, 2019, as provided in the definitive information statement filed with Securities and Exchange Commission on January 10, 2020 (the “DEF 14C”). The description of the 2020 Equity Plan is qualified in its entirety by the text of the 2020 Equity Plan, a copy of which was attached as Annex C to the DEF 14C. Amendment to the 2020 Stock Incentive Plan On January 8, 2024, our stockholders took action by written consent to ratify the amendment to the 2020 Stock Incentive Plan (the “2020 Plan”) approved by the Board of Directors on December 15, 2023. On December 15, 2023, our Board approved an amendment to the 2020 Plan to effect an increase in the number of shares that remain available for issuance under the 2020 Plan by an additional 2,150,000 shares up to an aggregate of 2,964,150 shares available for issuance under the 2020 Plan (the “2020 Plan Amendment”). Before the 2020 Plan Amendment, the number of shares available for issuance under the 2020 Plan would be too limited to effectively operate as an incentive and retention tool for employees, officers, directors, non-employee directors and consultants of the Company and its affiliates (as defined in the 2020 Plan). The 2020 Plan and the approved increase enabled us to continue our policy of equity ownership by employees, officers, directors, non-employee directors and consultants of the Company and its affiliates as an incentive to contribute to the creation of long-term value for our stockholders. 2024 Stock Incentive Plan Effective February 15, 2024, the Board of Directors adopted the 2024 Stock Incentive Plan (the “2024 Plan”) under which a total of 3,000,000 share of our common stock have been reserved for issuance of Incentive Stock Options, or ISOs, Non-Qualified Stock Options, or NSOs, restricted share awards, stock unit awards, SARs, other stock-based awards, performance-based stock awards, (collectively, “stock awards”) and cash-based awards (stock awards and cash-based awards are collectively referred to as “awards”). ISOs may be granted only to our employees, including officers, and the employees of our parent or subsidiaries. All other awards may be granted to our employees, officers, our non-employee directors, and consultants and the employees and consultants of our subsidiaries, and affiliates. The following table sets forth shares authorized and available under our incentive plans at December 31, 2024:
|  | Options Authorized |  |  | Options Granted |  |  | Options Exercised |  |  | Options Cancelled or Expired |  |  | Options Outstanding |  |  | Options Available to be Issued |
2016 Plan |  |  | 12,712 |  |  |  | 3,333 |  |  |  | - |  |  |  | 1,000 |  |  |  | 2,333 |  |  |  | 10,379 |
2020 Plan |  |  | 2,964,150 |  |  |  | 2,745,084 |  |  |  | 50,459 |  |  |  | 201,028 |  |  |  | 2,493,597 |  |  |  | 470,553 |
2024 Plan |  |  | 3,000,000 |  |  |  | 96,861 |  |  |  | - |  |  |  | 8,000 |  |  |  | 88,861 |  |  |  | 2,911,139 |
Outstanding Options The following is a summary of information about the Stock Options outstanding at December 31, 2024:
|  |  |  |  |  |  |  |  |  |  |  | Shares Underlying |
|  | Shares Underlying Options Outstanding |  |  | Options Exercisable |
|  |  |  |  |  |  | Weighted |  |  |  |  |  |  |  |  |
|  | Shares |  |  |  |  | Average |  | Weighted |  |  | Shares |  |  | Weighted |
|  | Underlying |  |  |  |  | Remaining |  | Average |  |  | Underlying |  |  | Average |
|  | Options |  |  | Range of |  | Contractual |  | Exercise |  |  | Options |  |  | Exercise |
|  | Outstanding |  |  | Exercise Prices |  | Life (in years) |  | Price |  |  | Exercisable |  |  | Price |
December 31, 2023 |  |  | 2,620,813 |  |  | $2.35 - $195.00 |  | 6.6 |  | $ | 19.38 |  |  |  | 271,259 |  |  | $ | 4.69 |
December 31, 2024 |  |  | 2,584,791 |  |  | $2.35 - $40.00 |  | 8.35 |  | $ | 20.06 |  |  |  | 552,856 |  |  | $ | 6.56 |
The following is a summary of activity of outstanding stock options at December 31, 2024:
|  |  |  |  | Weighted |  |  |  |
|  |  |  |  | Average |  |  | Average |
|  | Number |  |  | Exercise |  |  | Intrinsic |
|  | of Shares |  |  | Prices |  |  | Value |
Balance, December 31, 2022 |  |  | 590,991 |  |  | $ | 4.53 |  |  | $ | 2,677,189 |
Options granted |  |  | 2,050,905 |  |  |  | 23.55 |  |  |  |
Options cancelled |  |  | (21,083 | ) |  |  | (2.84 | ) |  |  |
Balance, December 31, 2023 |  |  | 2,620,813 |  |  | $ | 19.38 |  |  | $ | 50,802,052 |
Options granted |  |  | 118,111 |  |  |  | 15.37 |  |  |  |
Options exercised |  |  | (50,459 | ) |  |  | (3.25 | ) |  |  |
Options cancelled |  |  | (88,850 | ) |  |  | (6.84 | ) |  |  |
Options expired |  |  | (14,824 | ) |  |  | (9.67 | ) |  |  |
Balance, December 31, 2024 |  |  | 2,584,791 |  |  | $ | 20.06 |  |  | $ | 51,844,122 |
Exercisable, December 31, 2024 |  |  | 552,856 |  |  | $ | 6.37 |  |  | $ | 3,521,693 |
Options Granted During the twelve months ended December 31, 2024, 25 employees were granted options to purchase an aggregate of 118,111 shares of the Company's common stock, having a weighted average exercise price of $15.37, exercisable over a 10-year term. The options will vest 60% on the third anniversary, and 20% each anniversary thereafter until fully vested. The Company uses the Black-Scholes Pricing Model to determine the fair value of options at the grant date. Inputs to this model include, expected term, risk-free interest rate, volatility, and the dividend rate. Due to a limited exercise history, the Company uses the simplified method of calculating expected term, which results in expected term of 6.8 years options granted in 2024. The Company uses an interest rate from the U.S. Department of the Treasury’s published yield curve which corresponds to the expected term. The annualized monthly volatility rate was 92 to 97%. The weighted average estimated fair value using the Black-Scholes Pricing Model, based on these inputs was $12.38, per share, or $1,462,214 total expense. The options are being expensed over the vesting period. Options Cancelled or Forfeited Approximately 88,850 options with a weighted average strike price of $9.67 per share were forfeited by former employees during the twelve months ended December 31, 2024. Reductions to share compensation expense recognized at the time of forfeiture. Options Expired During the twelve months ended December 31, 2024, options expirations consisted of 333 options with a $112.20 strike price, and 14,491 options with a $5.41 strike price. Options Exercised A total of 50,459 options were exercised during the twelve months ended December 31, 2024. No options were exercised during the twelve months ended December 31, 2023. Proceeds from options exercises during the twelve months ended December 31, 2024 amounted to $163,854. Options Exercisable There were 552,856 options exercisable as of December 31, 2024. Options Expense The Company recognized compensation expense net of forfeitures related to common stock options that are being amortized over the implied service term, or vesting period, of the options during the twelve months ended December 31, 2024 and 2023, as follows:
|  | For the Year Ended |
|  | December 31, |
|  | 2024 |  |  | 2023 |
Directors |  | $ | 86,892 |  |  | $ | 91,990 |
Officers |  |  | 4,214,949 |  |  |  | 238,932 |
Employees |  |  | 209,815 |  |  |  | 68,304 |
Total amortized options expense |  | $ | 4,511,656 |  |  | $ | 711,037 |
As of December 31, 2024, the remaining unamortized balance to be expensed over the next five years is $11,083,090 and the weighted-average period over which these awards are expected to be recognized is approximately 1.65 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration